In the NAFLD liver, modulation of miR-15b may be correlated with the pathogenesis of hepatic insulin resistance, as it directly targets the insulin receptor (INSR) [139]. The gene discussed is INSR; the disease is metabolic dysfunction-associated steatotic liver disease.